Featured series 
Tag: Andrew Chan
-
Health
New thinking on aspirin and colorectal cancer needs dose of nuance, expert says
The Gazette spoke with Andrew Chan, director of cancer epidemiology at the Mass. General Cancer Center, about the new thinking around aspirin.
-
Health
(Not) feeling the burn
A study of diet has found that by adhering to specific guidelines, women can reduce more than one-third of incidence of gastroesophageal reflux disease symptoms.
-
Health
Loss of taste and smell is best indicator of COVID-19, study shows
Researchers deploying a smartphone app to 2.6 million users have determined that the loss of smell and taste are most predictive symptoms of COVID-19.
-
Health
Aspirin found to reduce overall cancer risk
An analysis of data from two long-term epidemiologic studies has found that regular use of aspirin significantly reduces the overall risk of cancer, an effect that primarily reflects a lower risk of colorectal cancer and other tumors of the gastrointestinal tract.
-
Health
Postdiagnosis aspirin use reduces risk of dying from colorectal cancer
Regular use of aspirin after colorectal cancer diagnosis may reduce the risk of cancer death, report Harvard researchers at Massachusetts General Hospital (MGH), Dana-Farber Cancer Institute (DFCI) and Brigham and Women’s Hospital. In today’s edition of the Journal of the American Medical Association, the study’s authors also find that the aspirin-associated survival advantage was seen…
-
Health
Sense of security may be false with tried and true anti-inflammatories
For all the tender joints and headaches they relieve and colon cancer they may prevent, the older nonsteroidal anti- inflammatory drugs (NSAIDs) raise another serious health risk. The highly publicized danger of heart attacks and other cardiovascular side effects first discovered in randomized control trials of newer, selective NSAIDs are being found in the older…